Perioperative cimetidine application modulates natural killer cells in patients with colorectal cancer: A randomized clinical study

Abstract

Thirty-eight colorectal cancer patients were randomly assigned to treatment group, which took cimetidine in the perioperative period, and control group to which no drug was given. Twenty healthy volunteers served as normal controls. NK cells were measured by immunocytochemical technique. The results showed that NK percentages before treatment in both groups of patients were significantly lower than those in normal controls (P<0. 05). NK cell percentages at admission, before operation, on the 2nd and the 10th postoperative days were 14.84 ±4. 41, 15. 74±3. 75, 17.21±3.69, 21.05±4. 54, respectively, for the treatment group, and 15.00±2.77, 13.05±2.46, 14. 21±2.19, 15.58±1.68, respectively, for control group. The difference was statistically significant (P< 0. 01), suggesting that the perioperative administration of cimetidine could help restore NK cells in colorectal cancer patients.

Keywords

cimetidine / natural killer cells / colorectal cancer

References

[1] AdamsW J, MorrisD L, RossW B, et al.. Cimetidine preserves non-specific immune function after colonic resection for cancer. Aust N Z J Surg, 1994, 64: 847-847

[2] CocaS, Perez-PiquerasJ, MartinezD, et al.. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer, 1997, 79: 2320-2320

[3] TrinchieriG, PerussiaB. Human natural killer cells: biologic and pathologic aspects. Lab Invest, 1984, 50: 489-489

[4] WiltroutR H, HerbermanR B, ZhangS R, et al.. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol, 1985, 134: 4267-4267

[5] HansbroughJ F, BenderE M, Zapata-SirventR, et al.. Altered helper and suppressor lymphocyte populations in surgical patients: a measure of postoperative immunosuppression. Am J Surg, 1984, 48: 303-303

[6] NicholsP H, RamsdenC W, WardU, et al.. Perioperative immunotherapy with recombinant interleukin 2 in patients undergoing surgery for colorectal cancer. Cancer Res, 1992, 52: 5765-5765

[7] EspiA, ArenasJ, Garcia-GraneroE, et al.. Relationship of curative surgery on natural killer cell activity in colorectal cancer. Dis Colon Rectum, 1996, 39: 429-429

[8] SedmanP C, RamsdenC W, BrennanT G, et al.. Effects of low dose perioperative interferon on the surgically induced suppression of antitumor immune responses. Br J Surg, 1988, 75: 976-976

[9] NicholsP H, RamsdenC W, WardU, et al.. Perioperative modulation of cellular immunity in patients with colorectal cancer. Clin Ex Immunol, 1993, 94: 4-4

[10] KikuchiY, OomoriK, KizawaI, et al.. Effects of cimetidine on tumor growth and immune function in nude mice bearing human ovarian carcinoma. J Natl Cancer Inst, 1985, 74: 495-495

[11] 1995;15(l):77

[12] AllenJ I, SyropoulosH J, GrantB, et al.. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia. J Lab Clin Med, 1987, 109: 396-396

[13] 1995;17(3):223